DK190286A - O-sulfaterede beta-lactam-hydroxyamsyrer - Google Patents

O-sulfaterede beta-lactam-hydroxyamsyrer Download PDF

Info

Publication number
DK190286A
DK190286A DK190286A DK190286A DK190286A DK 190286 A DK190286 A DK 190286A DK 190286 A DK190286 A DK 190286A DK 190286 A DK190286 A DK 190286A DK 190286 A DK190286 A DK 190286A
Authority
DK
Denmark
Prior art keywords
lactam
sulphated
beta
hydroxyamic acids
hydroxyamic
Prior art date
Application number
DK190286A
Other languages
English (en)
Other versions
DK190286D0 (da
Inventor
Joseph E Sundeen
William H Koster
Robert Zahler
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK190286D0 publication Critical patent/DK190286D0/da
Publication of DK190286A publication Critical patent/DK190286A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

eller n og m hver især er 1, og X er -S-CHj-S,
Figure DK190286AD00021
,
Figure DK190286AD00022
eller
Figure DK190286AD00023
R2 er alkyl, aryl, hydroxy, alkoxy, alkanoyloxy, carbamoyloxy, alkanoylamino eller ureido, er hydrogen, alkyl, aryl, alkanoyl eller carbamoyl, og R4 er hydrogen, alkyl eller aryl, har antibakteriel aktivitet og er virksomme mod gram-positive og gram-negative organismer.
Forbindelserne og deres salte kan anvendes i lægemidler til bekæmpelse af f.eks. urinvejs- og åndedrætsinfektioner.
DK190286A 1985-04-29 1986-04-24 O-sulfaterede beta-lactam-hydroxyamsyrer DK190286A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/728,432 US4638060A (en) 1985-04-29 1985-04-29 O-sulfated spiro β-lactam hydroxamic acids
US72843285 1985-04-29

Publications (2)

Publication Number Publication Date
DK190286D0 DK190286D0 (da) 1986-04-24
DK190286A true DK190286A (da) 1986-10-30

Family

ID=24926831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK190286A DK190286A (da) 1985-04-29 1986-04-24 O-sulfaterede beta-lactam-hydroxyamsyrer

Country Status (20)

Country Link
US (1) US4638060A (da)
JP (1) JPS61257965A (da)
AU (1) AU601944B2 (da)
BE (1) BE904699A (da)
CA (1) CA1273938A (da)
CH (1) CH668073A5 (da)
DE (1) DE3614317A1 (da)
DK (1) DK190286A (da)
ES (1) ES8800916A1 (da)
FI (1) FI861693A (da)
FR (1) FR2581062B1 (da)
GB (1) GB2174392B (da)
HU (1) HU194822B (da)
IE (1) IE59630B1 (da)
IT (1) IT1215652B (da)
NL (1) NL8601051A (da)
NZ (1) NZ215665A (da)
PT (1) PT82467B (da)
SE (1) SE8601963L (da)
ZA (1) ZA862429B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN113975396B (zh) * 2021-11-09 2022-11-29 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260743A (en) * 1979-12-31 1981-04-07 Gist-Brocades N.V. Preparation of β-lactams and intermediates therefor
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS586589A (ja) 1981-07-01 1983-01-14 Hitachi Ltd 論理回路
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規2−アゼチジノン誘導体

Also Published As

Publication number Publication date
NZ215665A (en) 1988-11-29
IT8620227A0 (it) 1986-04-28
FR2581062B1 (fr) 1990-10-19
CA1273938C (en) 1990-09-11
IT1215652B (it) 1990-02-22
ES8800916A1 (es) 1987-12-01
SE8601963L (sv) 1986-10-30
IE59630B1 (en) 1994-03-09
JPS61257965A (ja) 1986-11-15
IE861067L (en) 1986-10-29
CH668073A5 (fr) 1988-11-30
DE3614317A1 (de) 1986-11-06
ES554438A0 (es) 1987-12-01
DK190286D0 (da) 1986-04-24
AU601944B2 (en) 1990-09-27
FI861693A (fi) 1986-10-30
PT82467A (en) 1986-05-01
GB8609596D0 (en) 1986-05-21
NL8601051A (nl) 1986-11-17
AU5556886A (en) 1986-11-06
ZA862429B (en) 1986-11-26
PT82467B (pt) 1988-03-03
US4638060A (en) 1987-01-20
GB2174392B (en) 1988-11-09
HUT41384A (en) 1987-04-28
SE8601963D0 (sv) 1986-04-28
BE904699A (fr) 1986-08-18
HU194822B (en) 1988-03-28
FR2581062A1 (fr) 1986-10-31
GB2174392A (en) 1986-11-05
CA1273938A (en) 1990-09-11
FI861693A0 (fi) 1986-04-22

Similar Documents

Publication Publication Date Title
GR79425B (da)
IL88107A0 (en) Aminomethyloxooxazolidinyl ethenyl-benzene derivatives,their preparation and antibacterial composition containing them
DK190286A (da) O-sulfaterede beta-lactam-hydroxyamsyrer
IE863381L (en) Antibiotics
DK312688A (da) Glykkopeptid-antibiotika
NO865323L (no) Antibiotisk virksomme a40926 n-acylaminoglukuronyl-aglykoner, antibiotikum a40926 aglykon, samt fremgangsmaater for fremstilling av disse stoffene.
DE3888587T2 (de) AB-006-Antibiotika und Verfahren zu deren Herstellung.
PT78418A (de) Neue kristallmodifikation von ceftazidim
Thomas et al. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin
EP0157544A3 (en) Antibiotics, their production and use
FR2401162A1 (fr) Antibiotique derive d'un streptomyces, utilisable comme medicament
ES8300773A1 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".
DK431284A (da) Antibiotisk forbindelse betegnet cl-1957b eller salte deraf, dens fremstilling samt dens anvendelse
DK283186D0 (da) Antibiotikum tan-749, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende det
Rey et al. Tsukamurella infections. Case report and literature review
Lode Co-trimoxazole from the therapeutic viewpoint
EP0365329A3 (en) Antibiotics active against anaerobic bacteria, their production and use, and strains of enterobacter producing the same
JPS56127381A (en) Beta-lactam compound and its preparation
Herrera et al. In vitro activity of 4 cephalosporins on hospital-acquired gram-negative bacteria and Staphylococcus aureus.
PT83712B (pt) Processo para a preparacao de derivados de cefalosporina
JPS57109786A (en) Antibiotic c-19393e5 and its preparation
DE69621939T2 (de) Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen
Wysocki et al. The changing pattern of infecting organisms
Corcoran Molecular biology of sensitivity and resistance to antimicrobial agents.
Gentry et al. A random comparative trial of 0 multiplied by 25, 0 multiplied by 5 and 1 multiplied by 0 g ceftazidime twice daily in urinary tract infection.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment